Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ac-kpssppee-nh2
2. Ac-lys-pro-ser-ser-pro-pro-glu-glu-nh2
3. Acetyl-lysyl-prolyl-seryl-seryl-prolyl-prolyl-glutamyl-glutamic Acid Amide
4. Urokinase Plasminogen Activator (136-143), Human
1. Nsc750394
2. Nsc-750394
Molecular Weight | 911.0 g/mol |
---|---|
Molecular Formula | C39H62N10O15 |
XLogP3 | -7.6 |
Hydrogen Bond Donor Count | 11 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 25 |
Exact Mass | 910.43961131 g/mol |
Monoisotopic Mass | 910.43961131 g/mol |
Topological Polar Surface Area | 391 Ų |
Heavy Atom Count | 64 |
Formal Charge | 0 |
Complexity | 1750 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 8 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9291
Submission : 1991-08-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9291
Submission : 1991-08-27
Status : Inactive
Type : II
About the Company : Cerbios is a privately held company located in Lugano, Switzerland. Cerbios is the ideal CDMO partner from clinical to commercial supply of ADCs, HPAPIs, Proteins and Antibodies. ...
About the Company : Hanways Chempharm Co., Limited, the former one is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We are engaged in supplying APIs, pharmaceutical intermediate...
Details:
The Agreement provides for Sequel to fund and undertake the necessary work to return Kinlytic (urokinase), a thrombolytic agent obtained from human neonatal kidney cells grown in tissue culture, to the U.S. for the clinical indication of venous catheter clearance.
Lead Product(s): Urokinase
Therapeutic Area: Hematology Brand Name: Kinlytic
Study Phase: ApprovedProduct Type: Large molecule
Sponsor: Sequel Pharma
Deal Size: $35.0 million Upfront Cash: Undisclosed
Deal Type: Agreement May 16, 2023
Lead Product(s) : Urokinase
Therapeutic Area : Hematology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Sequel Pharma
Deal Size : $35.0 million
Deal Type : Agreement
Microbix Secures Funded Drug Commercialization Agreement
Details : The Agreement provides for Sequel to fund and undertake the necessary work to return Kinlytic (urokinase), a thrombolytic agent obtained from human neonatal kidney cells grown in tissue culture, to the U.S. for the clinical indication of venous catheter ...
Brand Name : Kinlytic
Molecule Type : Large molecule
Upfront Cash : Undisclosed
May 16, 2023
RLD :
TE Code :
Brand Name : KINLYTIC
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 250,000 IU/VIAL
Approval Date :
Application Number : 21846
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Brand Name : KINLYTIC
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 9,000 IU/VIAL
Approval Date :
Application Number : 21846
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Brand Name : KINLYTIC
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 5,000 IU/VIAL
Approval Date :
Application Number : 21846
RX/OTC/DISCN :
RLD :
TE Code :
Regulatory Info :
Registration Country : Italy
Acetyl-Lysyl-Prolyl-Seryl-Seryl-Prolyl-Prolyl-Glutamyl-Glutamic Acid Amide
Brand Name : Urokinasi
Dosage Form : Urokinase 100.000Iu 2Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle 100,000 IU + 1 ampoule solv 2 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Acetyl-Lysyl-Prolyl-Seryl-Seryl-Prolyl-Prolyl-Glutamyl-Glutamic Acid Amide
Brand Name : Genkinase
Dosage Form : Urokinase 1.000.000Iu 5Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle 1,000,000 IU + 1 ampoule solv 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Acetyl-Lysyl-Prolyl-Seryl-Seryl-Prolyl-Prolyl-Glutamyl-Glutamic Acid Amide
Brand Name : Urokinase
Dosage Form : Urokinase 1.000.000Iu 5Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle 1,000,000 IU + 1 ampoule solv 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Acetyl-Lysyl-Prolyl-Seryl-Seryl-Prolyl-Prolyl-Glutamyl-Glutamic Acid Amide
Brand Name : Genkinase
Dosage Form : Urokinase 100.000Iu 2Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle 100,000 IU + 1 ampoule solv 2 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Acetyl-Lysyl-Prolyl-Seryl-Seryl-Prolyl-Prolyl-Glutamyl-Glutamic Acid Amide
Brand Name : Urokinase
Dosage Form : Urokinase 100.000Iu 2Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle 100,000 IU + 1 ampoule solv 2 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Acetyl-Lysyl-Prolyl-Seryl-Seryl-Prolyl-Prolyl-Glutamyl-Glutamic Acid Amide
Brand Name : Urokinase
Dosage Form : Urokinase 25,000Iu 2Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle 25,000 IU + 1 ampoule solv 2 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Acetyl-Lysyl-Prolyl-Seryl-Seryl-Prolyl-Prolyl-Glutamyl-Glutamic Acid Amide
Brand Name : Genkinase
Dosage Form : Urokinase 500.000Iu 5Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle 500,000 IU + 1 ampoule solv 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Acetyl-Lysyl-Prolyl-Seryl-Seryl-Prolyl-Prolyl-Glutamyl-Glutamic Acid Amide
Brand Name : Urokinase
Dosage Form : Urokinase 500.000Iu 5Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle 500,000 IU + 1 ampoule solv 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Vial
Dosage Strength : 500000IU
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Vial
Dosage Strength : 500000IU
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Urokinase manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Urokinase, including repackagers and relabelers. The FDA regulates Urokinase manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Urokinase API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Urokinase manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Urokinase supplier is an individual or a company that provides Urokinase active pharmaceutical ingredient (API) or Urokinase finished formulations upon request. The Urokinase suppliers may include Urokinase API manufacturers, exporters, distributors and traders.
click here to find a list of Urokinase suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Urokinase DMF (Drug Master File) is a document detailing the whole manufacturing process of Urokinase active pharmaceutical ingredient (API) in detail. Different forms of Urokinase DMFs exist exist since differing nations have different regulations, such as Urokinase USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Urokinase DMF submitted to regulatory agencies in the US is known as a USDMF. Urokinase USDMF includes data on Urokinase's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Urokinase USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Urokinase suppliers with USDMF on PharmaCompass.
Urokinase Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Urokinase GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Urokinase GMP manufacturer or Urokinase GMP API supplier for your needs.
A Urokinase CoA (Certificate of Analysis) is a formal document that attests to Urokinase's compliance with Urokinase specifications and serves as a tool for batch-level quality control.
Urokinase CoA mostly includes findings from lab analyses of a specific batch. For each Urokinase CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Urokinase may be tested according to a variety of international standards, such as European Pharmacopoeia (Urokinase EP), Urokinase JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Urokinase USP).
LOOKING FOR A SUPPLIER?